⌘K

Home/Filings/4/0001012975-17-000635

4//SEC Filing

Enright William 4

Accession 0001012975-17-000635

CIK 0001326190other

View on SEC.gov Company Profile

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 4:45 PM ET

Size

10.3 KB

Accession

0001012975-17-000635

Insider Transaction Report

Form 4

Period: 2017-08-16

Altimmune, Inc.ALT

Enright William

DirectorPresident and CEO

Transactions

Exercise/Conversion
Stock Options (option to buy)
2017-08-16−71,644→ 0 total
Exercise: $0.08From: 2017-05-04Exp: 2019-12-31→ Common Stock (71,644 underlying)
Exercise/Conversion
Stock Options (option to buy)
2017-08-16−91,733→ 0 total
Exercise: $0.08From: 2017-05-04Exp: 2021-12-03→ Common Stock (91,733 underlying)
Exercise/Conversion
Common Stock
2017-08-16$0.08/sh+71,644$5,732→ 89,431 total
Exercise/Conversion
Common Stock
2017-08-16$0.08/sh+91,733$7,339→ 181,164 total

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1

filerCIK 0001705564

Filing Metadata

Form type: 4
Filed: Aug 17, 8:00 PM ET
Accepted: Aug 18, 4:45 PM ET
Size: 10.3 KB

View on SEC.gov